Eli Lilly bets $2.75 billion on Insilico Medicine: is this AI drug discovery’s ‘GPT moment’?
By Hualin Wuwang Another traditional industry has officially fallen for AI. On March 29, US pharmaceutical…
Latest
- Han’s CNC rides AI infrastructure boom, but expansion brings new risks
- China demonstrates novel net-catch rocket recovery system as it races to close the gap with SpaceX
- China turns to molten salt to tackle renewable energy storage bottlenecks in the national grid
- Dramatic slowdown in China’s range-extended electric vehicle market raises concerns over Xiaomi’s strategy
- Biokin’s new cancer drug secures historic approval in China, but Western regulatory hurdles loom
